Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Utrecht
SEC filing record 1 source field available
Fiscal year end
31 December
LAVA Therapeutics NV has filed 169 SEC EDGAR filings since 25 Jan 2021

SEC filing history

Showing 1-25 of 169 matching filings.

Per page
25
Current page
1
15-12G File 001-40241

15-12G

Filing date
16 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE/A File 001-40241

25-NSE/A filing

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-286228

S-8 POS

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-256655

S-8 POS

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-92425

SC 14D9/A

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-92425

SC TO-T/A

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-92425

SC 14D9/A

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-92425

SC TO-T/A

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9/A File 005-92425

SC 14D9/A

Filing date
10 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92425

SCHEDULE 13D/A filing

Filing date
22 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Oct 2025
Reporting date
16 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92425

SCHEDULE 13D/A filing

Filing date
17 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .